IS
Isha Soni
UCSF Medical Center, University of Utah, CSIR-Central Drug Research Institute, Banasthali University Department of Bioscience and Biotechnology
0000-0003-1506-7294
Employment
-
UCSF Medical Center Postdoc2021 - Present
-
University of Utah Postdoc2019 - 2021
Education
-
CSIR-Central Drug Research Institute PhD2012 - 2018
-
Banasthali University Department of Bioscience and Biotechnology Masters in Biotechnology2007 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (16)
- Phage and Antibiotic Combinations Reduce Staphylococcus aureus in Static and Dynamic Biofilms Grown on an Implant Material Save
- Synthesis and Biological Studies of Dodecameric Cationic Antimicrobial Peptides Containing Tetrahydrofuran Amino Acids. Save
- Chemoproteomics of an Indole-Based Quinone Epoxide Identifies Druggable Vulnerabilities in Vancomycin-Resistant Staphylococcus aureus. Save
- Biocatalytic synthesis of diaryl disulphides and their bio-evaluation as potent inhibitors of drug-resistant Staphylococcus aureus. Save
- Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii. Save
- Drugs Under Preclinical and Clinical Testing for the Treatment of Infections Caused due to Staphylococcus aureus: An Update Save
- Drugs under preclinical and clinical testing for the treatment of infections caused due to staphylococcus aureus: An update Save
- Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections. Save
- Synthesis and biological evaluation of indole-based 2-Aryl-2,3-epoxy-1,4-naphthoquinones as methicillin-resistant staphylococcus aureus (MRSA) inhibitors Save
- Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria. Save